APPOS Charlotte 2025 |
- 11.00 AMA PRA Category 1 Credit™
- 11.00 ANCC
- 11.00 ACPE Pharmacy
- 2.25 Pharmacology
|
Live |
02/28/2025 - 4:00am PST |
$115.00 |
APPOS Minneapolis 2025 |
- 10.25 AMA PRA Category 1 Credit™
- 10.25 ANCC
- 10.25 ACPE Pharmacy
- 4.75 Pharmacology
|
Live |
03/21/2025 - 5:00am PDT |
$115.00 |
APPOS Boston 2025 |
- 10.25 AMA PRA Category 1 Credit™
- 10.25 ANCC
- 10.25 ACPE Pharmacy
- 4.50 Pharmacology
|
Live |
03/14/2025 - 4:00am PDT |
$115.00 |
Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) Winter 2024 |
- 14.00 AMA PRA Category 1 Credit™
- 14.00 ANCC
- 2.25 Pharmacology
|
Enduring |
|
$125.00 |
Neuroendocrine Neoplasms: Not All Hoofbeats Are Horses |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Revolutionizing Leukemia Treatment: Allogeneic Transplants, Engineered T Cell Therapy, and Navigating the Complexities of GVHD |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Nutritional Strategies in Cancer Care: The Role of Enteral Nutrition |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Expanding the Role of Immunotherapy: New Regimens for Use in the Adjuvant and Neoadjuvant Settings |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Hitting the Target: Updates and Review in Genotype Directed Therapy for Non-Small Cell Lung Cancer |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Navigating the Terrain: Insights into the Current Landscape, Treatment Strategies, and a Clinical Trial of Triple Negative Breast Cancer |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
|
Enduring |
|
$0.00 |
Melanoma Management in 2024 |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Integrative Oncology: Supporting Healing Before, During, and After |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Updates in Lymphoma 2024 |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Updates in Management of Advanced Renal Cell Carcinoma: Making Sense of the Menu |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
Current Treatment Paradigms for Head and Neck Cancers |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |